A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma

Registros relacionados

• A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
  por: Midgley, R, et al.
  Publicado em: (2002)
• A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
  por: Palmer, D, et al.
  Publicado em: (2009)
• Dendritic cell vaccination for hepatocellular carcinoma.
  por: Midgley, R, et al.
  Publicado em: (2003)
• Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
  por: Jeong-Hoon Lee, et al.
  Publicado em: (2017-07-01)
• Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
  por: Raquel S Laureano, et al.
  Publicado em: (2022-12-01)